[The clinical evaluation of the serum SCC antigen levels with "SCC RIABEAD" by immunoradiometric assay].
The clinical significance of serum SCC antigen level was evaluated by the monoclonal antibody method (SCC.RIABEAD Dinabot Co. Ltd). Patients with squamous cell carcinoma showed a high positive SCC antigen level and positive rate elevated with the advance of the clinical stage. The serum SCC antigen level was decreased by treatment, and it increased again before obvious clinical recurrence was recognized. The results suggest that measurement of serum SCC antigen level is useful as a follow up of cancer treatment.
Yoshida
Y
Y
Department of Radiology, Kagawa Medical School Hospital, Japan.
Takashima
H
H
Kawasaki
Y
Y
Yasuda
S
S
Tamai
T
T
Hosokawa
N
N
Miyamoto
T
T
Matuno
S
S
Sakamoto
K
K
Nakase
S
S
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis; D002294:Carcinoma, Squamous Cell / Q000276:immunology*; D005260:Female; D006801:Humans; D008297:Male; D011863:Radioimmunoassay; D015843:Serpins
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D015843:Serpins; C051072:squamous cell carcinoma-related antigen